Small molecules that bind to alpha-synuclein deposition and can be used for PET imagining in patients with synucleinopathies
Thioamide-stabilized peptide specifically inhibiting cathepsin L to block SARS-CoV-2 entry and cancer cell migration
N-Terminal protein modification using adenosine substrates and aminoacyl transferase
Fluorescently labeled α-synuclein to examine destabilization of synuclein fibrils by small molecules and therapeutics for neurodegenerative diseases
Natural bioactive peptides and hormones with thioamide substitutions at cleavage sites for improved pharmacokinetics